KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Q1 2026 Earnings Call Transcript September 11, 2025
KalVista Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.12 EPS, expectations were $-0.91.
Operator: Ladies and gentlemen, thank you for standing by. Welcome to KalVista Pharmaceuticals operational update and First Fiscal Quarter Financial Results. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to turn the...
